Manas AI’s Post

We are closer to possible than we’ve ever been. Today, we announce the launch of Manas AI, and setting out to shift drug discovery from a decade-long process to one that takes a few years; bringing life-saving treatments to patients years faster than ever.  In the beginning, our primary focus will be in oncology, developing treatments for aggressive cancers such as triple-negative breast cancer, prostate cancer, and lymphoma. The promise of Artificial Intelligence is human amplification. Nobel laureates, National Academy members, and pioneering researchers who've dedicated their lives to understanding disease working hand-in-hand with advanced AI systems, exploring chemical spaces and analyzing molecular interactions at speeds 100 times faster than traditional methods. That’s what we’re building at Manas AI. Like many of you, my co-founder Dr. Siddhartha Mukherjee and I both have had people close to us affected by cancer and other diseases. When we first discussed creating Manas AI we shared a vision of a future where breakthrough treatments don't take decades to develop. Where AI helps us explore possibilities that human researchers alone might never have time to investigate. Where technology serves as a force multiplier for human ingenuity. While we're still in the early stages of contemporary AI development, initiatives like Manas AI show how close we already are to advances that can profoundly change the world. Read more here https://lnkd.in/ebBwNu7H or in today’s WSJ: https://lnkd.in/eJR7xe2Y

We are closer to possible than we’ve ever been. Today, we announce the launch of Manas AI, and setting out to shift drug discovery from a decade-long process to one that takes a few years; bringing life-saving treatments to patients years faster than ever.  In the beginning, our primary focus will be in oncology, developing treatments for aggressive cancers such as triple-negative breast cancer, prostate cancer, and lymphoma. The promise of Artificial Intelligence is human amplification. Nobel laureates, National Academy members, and pioneering researchers who've dedicated their lives to understanding disease working hand-in-hand with advanced AI systems, exploring chemical spaces and analyzing molecular interactions at speeds 100 times faster than traditional methods. That’s what we’re building at Manas AI. Like many of you, my co-founder Dr. Siddhartha Mukherjee and I both have had people close to us affected by cancer and other diseases. When we first discussed creating Manas AI we shared a vision of a future where breakthrough treatments don't take decades to develop. Where AI helps us explore possibilities that human researchers alone might never have time to investigate. Where technology serves as a force multiplier for human ingenuity. While we're still in the early stages of contemporary AI development, initiatives like Manas AI show how close we already are to advances that can profoundly change the world. Read more here https://lnkd.in/ebBwNu7H or in today’s WSJ: https://lnkd.in/eJR7xe2Y

We are closer to possible than we’ve ever been. Today, we announce the launch of Manas AI, and setting out to shift drug discovery from a decade-long process to one that takes a few years; bringing life-saving treatments to patients years faster than ever.  In the beginning, our primary focus will be in oncology, developing treatments for aggressive cancers such as triple-negative breast cancer, prostate cancer, and lymphoma. The promise of Artificial Intelligence is human amplification. Nobel laureates, National Academy members, and pioneering researchers who've dedicated their lives to understanding disease working hand-in-hand with advanced AI systems, exploring chemical spaces and analyzing molecular interactions at speeds 100 times faster than traditional methods. That’s what we’re building at Manas AI. Like many of you, my co-founder Dr. Siddhartha Mukherjee and I both have had people close to us affected by cancer and other diseases. When we first discussed creating Manas AI we shared a vision of a future where breakthrough treatments don't take decades to develop. Where AI helps us explore possibilities that human researchers alone might never have time to investigate. Where technology serves as a force multiplier for human ingenuity. While we're still in the early stages of contemporary AI development, initiatives like Manas AI show how close we already are to advances that can profoundly change the world. Read more here https://lnkd.in/ebBwNu7H or in today’s WSJ: https://lnkd.in/eJR7xe2Y

We are closer to possible than we’ve ever been. Today, we announce the launch of Manas AI, and setting out to shift drug discovery from a decade-long process to one that takes a few years; bringing life-saving treatments to patients years faster than ever.  In the beginning, our primary focus will be in oncology, developing treatments for aggressive cancers such as triple-negative breast cancer, prostate cancer, and lymphoma. The promise of Artificial Intelligence is human amplification. Nobel laureates, National Academy members, and pioneering researchers who've dedicated their lives to understanding disease working hand-in-hand with advanced AI systems, exploring chemical spaces and analyzing molecular interactions at speeds 100 times faster than traditional methods. That’s what we’re building at Manas AI. Like many of you, my co-founder Dr. Siddhartha Mukherjee and I both have had people close to us affected by cancer and other diseases. When we first discussed creating Manas AI we shared a vision of a future where breakthrough treatments don't take decades to develop. Where AI helps us explore possibilities that human researchers alone might never have time to investigate. Where technology serves as a force multiplier for human ingenuity. While we're still in the early stages of contemporary AI development, initiatives like Manas AI show how close we already are to advances that can profoundly change the world. Read more here https://lnkd.in/ebBwNu7H or in today’s WSJ: https://lnkd.in/eJR7xe2Y

We are closer to possible than we’ve ever been. Today, we announce the launch of Manas AI, and setting out to shift drug discovery from a decade-long process to one that takes a few years; bringing life-saving treatments to patients years faster than ever.  In the beginning, our primary focus will be in oncology, developing treatments for aggressive cancers such as triple-negative breast cancer, prostate cancer, and lymphoma. The promise of Artificial Intelligence is human amplification. Nobel laureates, National Academy members, and pioneering researchers who've dedicated their lives to understanding disease working hand-in-hand with advanced AI systems, exploring chemical spaces and analyzing molecular interactions at speeds 100 times faster than traditional methods. That’s what we’re building at Manas AI. Like many of you, my co-founder Dr. Siddhartha Mukherjee and I both have had people close to us affected by cancer and other diseases. When we first discussed creating Manas AI we shared a vision of a future where breakthrough treatments don't take decades to develop. Where AI helps us explore possibilities that human researchers alone might never have time to investigate. Where technology serves as a force multiplier for human ingenuity. While we're still in the early stages of contemporary AI development, initiatives like Manas AI show how close we already are to advances that can profoundly change the world. Read more here https://lnkd.in/ebBwNu7H or in today’s WSJ: https://lnkd.in/eJR7xe2Y

We are closer to possible than we’ve ever been. Today, we announce the launch of Manas AI, and setting out to shift drug discovery from a decade-long process to one that takes a few years; bringing life-saving treatments to patients years faster than ever.  In the beginning, our primary focus will be in oncology, developing treatments for aggressive cancers such as triple-negative breast cancer, prostate cancer, and lymphoma. The promise of Artificial Intelligence is human amplification. Nobel laureates, National Academy members, and pioneering researchers who've dedicated their lives to understanding disease working hand-in-hand with advanced AI systems, exploring chemical spaces and analyzing molecular interactions at speeds 100 times faster than traditional methods. That’s what we’re building at Manas AI. Like many of you, my co-founder Dr. Siddhartha Mukherjee and I both have had people close to us affected by cancer and other diseases. When we first discussed creating Manas AI we shared a vision of a future where breakthrough treatments don't take decades to develop. Where AI helps us explore possibilities that human researchers alone might never have time to investigate. Where technology serves as a force multiplier for human ingenuity. While we're still in the early stages of contemporary AI development, initiatives like Manas AI show how close we already are to advances that can profoundly change the world. Read more here https://lnkd.in/ebBwNu7H or in today’s WSJ: https://lnkd.in/eJR7xe2Y

We are closer to possible than we’ve ever been. Today, we announce the launch of Manas AI, and setting out to shift drug discovery from a decade-long process to one that takes a few years; bringing life-saving treatments to patients years faster than ever.  In the beginning, our primary focus will be in oncology, developing treatments for aggressive cancers such as triple-negative breast cancer, prostate cancer, and lymphoma. The promise of Artificial Intelligence is human amplification. Nobel laureates, National Academy members, and pioneering researchers who've dedicated their lives to understanding disease working hand-in-hand with advanced AI systems, exploring chemical spaces and analyzing molecular interactions at speeds 100 times faster than traditional methods. That’s what we’re building at Manas AI. Like many of you, my co-founder Dr. Siddhartha Mukherjee and I both have had people close to us affected by cancer and other diseases. When we first discussed creating Manas AI we shared a vision of a future where breakthrough treatments don't take decades to develop. Where AI helps us explore possibilities that human researchers alone might never have time to investigate. Where technology serves as a force multiplier for human ingenuity. While we're still in the early stages of contemporary AI development, initiatives like Manas AI show how close we already are to advances that can profoundly change the world. Read more here https://lnkd.in/ebBwNu7H or in today’s WSJ: https://lnkd.in/eJR7xe2Y

We are closer to possible than we’ve ever been. Today, we announce the launch of Manas AI, and setting out to shift drug discovery from a decade-long process to one that takes a few years; bringing life-saving treatments to patients years faster than ever.  In the beginning, our primary focus will be in oncology, developing treatments for aggressive cancers such as triple-negative breast cancer, prostate cancer, and lymphoma. The promise of Artificial Intelligence is human amplification. Nobel laureates, National Academy members, and pioneering researchers who've dedicated their lives to understanding disease working hand-in-hand with advanced AI systems, exploring chemical spaces and analyzing molecular interactions at speeds 100 times faster than traditional methods. That’s what we’re building at Manas AI. Like many of you, my co-founder Dr. Siddhartha Mukherjee and I both have had people close to us affected by cancer and other diseases. When we first discussed creating Manas AI we shared a vision of a future where breakthrough treatments don't take decades to develop. Where AI helps us explore possibilities that human researchers alone might never have time to investigate. Where technology serves as a force multiplier for human ingenuity. While we're still in the early stages of contemporary AI development, initiatives like Manas AI show how close we already are to advances that can profoundly change the world. Read more here https://lnkd.in/ebBwNu7H or in today’s WSJ: https://lnkd.in/eJR7xe2Y

We are closer to possible than we’ve ever been. Today, we announce the launch of Manas AI, and setting out to shift drug discovery from a decade-long process to one that takes a few years; bringing life-saving treatments to patients years faster than ever.  In the beginning, our primary focus will be in oncology, developing treatments for aggressive cancers such as triple-negative breast cancer, prostate cancer, and lymphoma. The promise of Artificial Intelligence is human amplification. Nobel laureates, National Academy members, and pioneering researchers who've dedicated their lives to understanding disease working hand-in-hand with advanced AI systems, exploring chemical spaces and analyzing molecular interactions at speeds 100 times faster than traditional methods. That’s what we’re building at Manas AI. Like many of you, my co-founder Dr. Siddhartha Mukherjee and I both have had people close to us affected by cancer and other diseases. When we first discussed creating Manas AI we shared a vision of a future where breakthrough treatments don't take decades to develop. Where AI helps us explore possibilities that human researchers alone might never have time to investigate. Where technology serves as a force multiplier for human ingenuity. While we're still in the early stages of contemporary AI development, initiatives like Manas AI show how close we already are to advances that can profoundly change the world. Read more here https://lnkd.in/ebBwNu7H or in today’s WSJ: https://lnkd.in/eJR7xe2Y